Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021

SELL
$51.81 - $118.56 $7.83 Million - $17.9 Million
-151,100 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$111.01 - $139.48 $2.45 Million - $3.08 Million
22,100 Added 17.13%
151,100 $16.8 Million
Q2 2020

Aug 12, 2020

BUY
$84.96 - $118.91 $3.84 Million - $5.37 Million
45,200 Added 53.94%
129,000 $11.6 Million
Q1 2020

May 13, 2020

BUY
$74.34 - $121.82 $4.22 Million - $6.91 Million
56,700 Added 209.23%
83,800 $8.35 Million
Q4 2019

Feb 12, 2020

BUY
$114.37 - $129.46 $3.1 Million - $3.51 Million
27,100 New
27,100 $3.11 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.76B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.